Peregrine Establishes China Subsidiary
This article was originally published in PharmAsia News
Executive Summary
Peregrine Pharmaceuticals has established a wholly foreign-owned subsidiary in China to tap the country's market opportunity, the Tustin, Calif. firm announced Jan. 12. The new division, Peregrine Beijing Pharmaceuticals Technology Development, is located in Beijing
You may also be interested in...
Novartis Shanghai R&D Center To Focus On Diseases Prevalent In China
Establishment of the R&D site reflects Novartis’ commitment to the region, according to the drug maker.
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).